Russell Investments Group Ltd. Trims Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Russell Investments Group Ltd. decreased its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 43.8% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 45,085 shares of the company’s stock after selling 35,202 shares during the period. Russell Investments Group Ltd. owned 0.05% of HealthEquity worth $2,647,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the stock. PNC Financial Services Group Inc. boosted its holdings in HealthEquity by 31.8% in the 1st quarter. PNC Financial Services Group Inc. now owns 13,547 shares of the company’s stock valued at $913,000 after purchasing an additional 3,266 shares during the period. AlphaCrest Capital Management LLC bought a new stake in HealthEquity during the first quarter valued at $234,000. Natixis Advisors L.P. purchased a new position in HealthEquity during the first quarter worth about $932,000. Bank of Montreal Can increased its stake in HealthEquity by 44.5% in the 1st quarter. Bank of Montreal Can now owns 8,218 shares of the company’s stock worth $553,000 after acquiring an additional 2,532 shares during the last quarter. Finally, Rhumbline Advisers raised its holdings in shares of HealthEquity by 2.2% in the 1st quarter. Rhumbline Advisers now owns 231,307 shares of the company’s stock valued at $15,599,000 after acquiring an additional 4,880 shares in the last quarter. Institutional investors own 98.80% of the company’s stock.

Insider Buying and Selling

In other HealthEquity news, CEO Jon Kessler sold 19,588 shares of the business’s stock in a transaction that occurred on Monday, June 26th. The stock was sold at an average price of $60.12, for a total value of $1,177,630.56. Following the completion of the sale, the chief executive officer now owns 6,129 shares in the company, valued at $368,475.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, EVP Elimelech Rosner sold 10,156 shares of the firm’s stock in a transaction dated Monday, June 12th. The stock was sold at an average price of $64.29, for a total value of $652,929.24. Following the sale, the executive vice president now directly owns 70,334 shares of the company’s stock, valued at $4,521,772.86. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jon Kessler sold 19,588 shares of the company’s stock in a transaction that occurred on Monday, June 26th. The shares were sold at an average price of $60.12, for a total value of $1,177,630.56. Following the transaction, the chief executive officer now owns 6,129 shares of the company’s stock, valued at approximately $368,475.48. The disclosure for this sale can be found here. 2.70% of the stock is owned by corporate insiders.

HealthEquity Price Performance

Shares of HealthEquity stock opened at $68.15 on Friday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 4.00 and a current ratio of 4.00. HealthEquity, Inc. has a 52-week low of $48.86 and a 52-week high of $79.20. The company has a fifty day moving average of $65.00 and a 200-day moving average of $61.20. The stock has a market capitalization of $5.82 billion, a price-to-earnings ratio of -681.50, a price-to-earnings-growth ratio of 2.55 and a beta of 0.82.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Monday, June 5th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.09. The business had revenue of $244.43 million during the quarter, compared to analyst estimates of $239.85 million. HealthEquity had a negative net margin of 0.93% and a positive return on equity of 4.30%. Equities research analysts expect that HealthEquity, Inc. will post 1.2 EPS for the current year.

Analysts Set New Price Targets

HQY has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft upped their price objective on shares of HealthEquity from $69.00 to $71.00 in a research report on Wednesday, June 7th. StockNews.com started coverage on shares of HealthEquity in a report on Thursday, August 17th. They issued a “hold” rating on the stock. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, HealthEquity has an average rating of “Moderate Buy” and an average target price of $82.33.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.